Progressive cerebellar ataxia with falsely positive anti-Ma2 antibodies
暂无分享，去创建一个
[1] M. Dalakas,et al. Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice , 2019, Neurotherapeutics.
[2] G. De Michele,et al. Degenerative and acquired sporadic adult onset ataxia , 2019, Neurological Sciences.
[3] R. Nitrini,et al. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes , 2018, Current Oncology Reports.
[4] Nuria Sola-Valls,et al. Síndromes neurológicos paraneoplásicos asociados a anticuerpos anti-Ma y anti-Ma2 , 2018 .
[5] W. Stoecker,et al. Letter to the editor re: "Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies" accurate evaluation of anti-NMDA-R cell-based assay avoids reporting of false positive results. , 2017, Clinical biochemistry.
[6] A. Vincent,et al. Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies. , 2017, Clinical biochemistry.
[7] N. Taştekin,et al. Laboratory evaluation in rheumatic diseases , 2017, World journal of methodology.
[8] J. Biller,et al. Treatable causes of cerebellar ataxia , 2015, Movement disorders : official journal of the Movement Disorder Society.
[9] F. Graus,et al. Identificación y utilidad clínica de los anticuerpos antineuronales , 2014 .
[10] M. Rosenfeld,et al. Clinical analysis of anti-Ma2-associated encephalitis. , 2004, Brain : a journal of neurology.